Latest Breaking News On - Array biopharma inc - Page 12 : comparemela.com

Press release content from Business Wire. The AP news staff was not involved in its creation. $304.5 Million Worldwide Dilated Cardiomyopathy Therapeutics Industry to 2027 - Impact of COVID-19 on the Market - ResearchAndMarkets.com December 16, 2020 GMT DUBLIN (BUSINESS WIRE) Dec 16, 2020 The publisher brings years of research experience to the 6th edition of this report. The 137-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. ADVERTISEMENT Global Dilated Cardiomyopathy Therapeutics Market to Reach $411.6 Million by 2027 Amid the COVID-19 crisis, the global market for Dilated Cardiomyopathy Therapeutics estimated at US$304.5 Million in the year 2020, is projected to reach a revised size of US$411.6 Million by 2027, growing at a CAGR of 4.4% over the analysis period 2020-2027.

United statesSouth koreaLaura woodArray biopharma incOffice hours callJanssen pharmaceuticals incTeva pharmaceutical industries ltdMerck co incE st office hours callPfizer incNovartis internationalVericel corporationCardiomyopathy therapeuticsMarket trajectoryDilated cardiomyopathy therapeutics marketDilated cardiomyopathy therapeutics